The results indicated that PGC-1α overexpression provides sufficient metabolic input and can reduce Notch1/Hes1 pathway activation, thereby alleviating AKI induced kidney inflammation, apoptosis and fibrosis. This evidence concerns the gene PPARGC1A and nephritis.